Bad time in biotech - Sales Benchling Employee Review

3.0
21 Jan 2026
Recommend
CEO approval
Business outlook

Pros

Competitive OTE and provides a satisfying challenge.

Cons

Biotech market is bad right now and only 1 or 2 salespersons are hitting quota so nobody is making close to their OTE. Constant turnover in leadership and lack of consistent direction

Explore other reviews about Benchling

5.0
16 Dec 2025
Recommend
CEO approval
Business outlook

Pros

1. Culture is great 2. Leadership is transparent 3. Business fundamentals are strong

Cons

1. Growing pains from being a mid stage company 2. Founders lack experience (but mitigate it well)

1
4.0
9 Mar 2026
Recommend
CEO approval
Business outlook

Pros

The leader in the R&D software industry

Cons

Lots of change in the sales org in the past year - previously unclear in its mission

See reviews by: Helpful|Rating|Date|All